| Title |
Author |
Type |
Date |
Words |
| New Roche Award for Antibody-based Cancer Therapy Research. |
|
|
May 15, 2013 |
627 |
| The Market for Pancreatic Cancer Therapies Will Nearly Double to $1.3 Billion in 2022, Fueled by the Entry of Three Novel Agents. |
|
|
May 7, 2013 |
505 |
| New target for personalized cancer therapy discovered. |
|
|
May 3, 2013 |
381 |
| Emu oil may help treat damage caused by cancer chemotherapy. |
|
|
Apr 16, 2013 |
189 |
| Mendelsohn To Talk Personalized Cancer Therapy at Bush Library and Museum April Issues Forum. |
|
|
Apr 16, 2013 |
657 |
| QVC and Fashion Footwear Association of New York Invest in Personalized Breast Cancer Therapy Research. |
|
|
Apr 4, 2013 |
903 |
| Merrimack Pharmaceuticals To Present Preclinical Research On Five Novel Cancer Therapies. |
|
|
Apr 2, 2013 |
731 |
| Premier Biomedical, Inc. Announces Next Phase of Laboratory Testing of its Anti-Cancer Therapy. |
|
|
Mar 28, 2013 |
613 |
| Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies. |
|
|
Mar 12, 2013 |
569 |
| Leica Biosystems and Synthon Biopharmaceuticals Partner to Develop a Companion Diagnostic Program for Targeted Cancer Therapies. |
|
|
Mar 12, 2013 |
574 |
| Drugs and Diagnostics for Hematological Disorders: Global Markets. |
|
|
Mar 12, 2013 |
7475 |
| MolecularHealth demonstrates Personalized Cancer Therapy Solutions at 2013 CeBIT. |
|
|
Mar 5, 2013 |
479 |
| RVC Biofund Portfolio Company to Contribute to Development of Cancer Therapy. |
|
|
Feb 20, 2013 |
1006 |
| Potential new anti-cancer therapy discovered. |
|
|
Feb 5, 2013 |
411 |
| Daiichi Sankyo and ArQule Enroll First Hepatocellular Carcinoma Patient into Global Phase 3 Trial for Tivantinib. |
|
|
Jan 31, 2013 |
1468 |
| CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Skin Cancer Therapies. |
|
|
Jan 31, 2013 |
1708 |
| Stress reduces effectiveness of prostate cancer therapies. |
|
|
Jan 29, 2013 |
165 |
| Stress reduces effectiveness of prostate cancer therapies. |
|
|
Jan 27, 2013 |
185 |
| Chinese medicine formula "Weikang Keli" induces autophagic cell death on human gastric cancer cell line SGC-7901. |
Huo, Jiege; Qin, Fengxia; Caic, Xueting; Ju, Jianming; Hu, Chunping; Wang, Zhigang; Lu, Wuguang; Wan |
Report |
Jan 15, 2013 |
4051 |
| Research and Markets: Closed Drug Transfer Systems. Therapeutic Markets, Strategies and Outlook. |
|
|
Jan 10, 2013 |
514 |
| Phase 3 DECISION Trial of Nexavar (sorafenib) Meets Primary Endpoint of Improving Progression-Free Survival in Patients with Radioactive Iodine Refractory Differentiated Thyroid Cancer. |
|
Clinical report |
Jan 3, 2013 |
1886 |
| A common cancer therapy to avoid--and a new, effective solution. |
|
|
Jan 1, 2013 |
1190 |
| Cellectis: An Innovative Anti-cancer Approach. |
|
|
Dec 18, 2012 |
950 |
| Alliance for Cancer Gene Therapy Funds Promising Leukemia Study - Patients in Remission More Than Two Years after Gene Therapy Treatment at UPenn. |
|
Report |
Dec 11, 2012 |
966 |
| Facilitating collaborations to develop combination investigational cancer therapies; workshop summary. |
|
Book review |
Dec 1, 2012 |
150 |
| Cancer drug 'may help eradicate latent HIV infection'. |
|
|
Dec 1, 2012 |
319 |
| Collegiate Inventors Honored for Innovative Science and Technology Advances. |
|
|
Nov 13, 2012 |
1414 |
| Insight Genetics Awarded Two National Cancer Institute Contracts to Enhance Precision in Cancer Care. |
|
|
Nov 12, 2012 |
877 |
| Northwest Bio Collaborating With Leading UK Cancer Institutions For DCVax-Direct Trial. |
|
|
Nov 6, 2012 |
1260 |
| Northwest Bio Collaborating With Leading UK Cancer Institutions For DCVax-Direct Trial. |
|
|
Nov 6, 2012 |
1295 |
| Research and Markets: Breast Cancer Therapies Markets. |
|
|
Nov 2, 2012 |
357 |
| Breast cancer and the Gerson Therapy. |
Sagarra, Rita |
|
Nov 1, 2012 |
1537 |
| Germany : QIAGEN and Bayer HealthCare partner to develop companion diagnostics to guide treatment decisions for targeted cancer therapies. |
|
|
Oct 27, 2012 |
391 |
| QIAGEN and Bayer HealthCare Partner to Develop Companion Diagnostics to Guide Treatment Decisions for Targeted Cancer Therapies. |
|
|
Oct 25, 2012 |
1442 |
| Abbott's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy. |
|
|
Oct 24, 2012 |
827 |
| Abbott's ALK Test is Now Available in Europe as a Companion Diagnostic Test to Aid in Identifying Patients for Targeted Lung Cancer Therapy. |
|
|
Oct 24, 2012 |
831 |
| Survivors Day Conference Webcast Focuses on Late Effects of Childhood Cancer Therapy. |
|
Conference news |
Oct 19, 2012 |
621 |
| New Step towards Nanotechnology-Assisted Cancer Therapy. |
|
|
Oct 14, 2012 |
294 |
| Study shows potential for more targeted lung cancer therapies. |
|
Brief article |
Oct 1, 2012 |
237 |
| Colby Pharmaceutical Announces SBIR Award for JunD Oncoprotein-Androgen Receptor (AR) Interaction Inhibitor Drugs in Novel Prostate Cancer Therapy. |
|
|
Oct 1, 2012 |
400 |
| Concord Medical Signs Framework Agreement to Establish a Cancer Specialty Hospital in the Beijing International Medical Center. |
|
|
Sep 20, 2012 |
651 |
| 20/20 GeneSystems to Present Data on Biomarker Panel to Improve Efficacy of Targeted Breast Cancer Therapy. |
|
Clinical report |
Sep 12, 2012 |
569 |
| VeriStrat Test Predicts Differential Treatment Benefit between Erlotinib Therapies for Lung Cancer Patients. |
|
|
Sep 6, 2012 |
876 |
| Breast cancer therapy safe in pregnancy: from the Lancet oncology. |
Moon, Mary Ann |
|
Sep 1, 2012 |
1078 |
| Compounds activate key cancer enzyme to interfere with tumor formation. |
|
Brief article |
Aug 27, 2012 |
135 |
| Research and Markets: Global Breast Cancer Drugs Market 2011-2015: The Global Breast Cancer Drugs Market to Grow at a CAGR of 1.7 Percent over the Period 2011-2015. |
|
|
Aug 13, 2012 |
382 |
| Cancer drug can flush out dormant HIV. |
|
|
Jul 26, 2012 |
400 |
| Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy. |
|
|
Jul 10, 2012 |
817 |
| Newman-Lakka Institute for Personalized Cancer Care at Floating Hospital for Children to accelerate the development of targeted cancer therapies. |
|
|
Jul 9, 2012 |
1043 |
| Research and Markets: Gene Therapy Market to 2018 - Product Development Slowed by Clinical Failures, Close Regulatory Surveillance and High Compliance Standards. |
|
|
Jul 9, 2012 |
402 |
| Marshall professor shares kidney research in China. |
|
Report |
Jul 1, 2012 |
294 |
| Research and Markets: Lung Cancer Therapy Annual - Recent Developments. |
|
|
Jun 20, 2012 |
244 |
| CSHL To Collaborate with Pfizer to Speed Development of New Cancer Therapies. |
|
|
Jun 20, 2012 |
443 |
| Research and Markets: Game Changers in Breast Cancer Therapies. |
|
|
Jun 13, 2012 |
345 |
| Precision Therapeutics Presents GeneFx[R] Colon Signature at the American Society of Colon and Rectal Surgery Symposium (ASCRS), the World's Largest Colorectal Conference. |
|
Conference news |
Jun 6, 2012 |
455 |
| Genentech's Targeted Investigational Breast Cancer Medicine, Trastuzumab Emtansine (T-DM1), Reduced the Risk of Cancer Worsening or Death by 35 Percent in Pivotal Phase III Trial. |
|
|
Jun 3, 2012 |
1494 |
| Integrative strategies for cancer patients; a practical resource for managing the side effects of cancer therapy. |
|
Book review |
Jun 1, 2012 |
160 |
| Fertility preservation is option for ca patients: methods are improving, and this is a real option to offer cancer patients. |
Brunk, Doug |
|
Jun 1, 2012 |
2097 |
| New cancer fighting strategy discovered. |
|
|
May 22, 2012 |
655 |
| Evodiamine, a dual catalytic inhibitor of type I and II topoisomerases, exhibits enhanced inhibition against camptothecin resistant cells. |
Pan, Xiaobei; Hartley, Janet M.; Hartley, John A.; White, Kenneth N.; Wang, Zhengtao; Bligh, S.W. An |
Report |
May 15, 2012 |
5405 |
| Diallyl sulfide, diallyl disulfide and diallyl trisulfide affect drug resistant gene expression in colo 205 human colon cancer cells in vitro and in vivo. |
Lai, Kuang-Chi; Kuo, Chao-Lin; Ho, Heng-Chien; Yang, Jai-Sing; Ma, Chia-Yu; Lu, Hsu-Feng; Huang, Hui |
Report |
May 15, 2012 |
4315 |
| Daily aspirin can cut death risk in bowel cancer patients. |
|
|
May 3, 2012 |
232 |
| IBN Discovers Human Neural Stem Cells with Tumor Targeting Ability - A Promising Discovery for Breast Cancer Therapy. |
|
|
Apr 20, 2012 |
1041 |
| Elekta Announces First Patients Treated with Major Breakthrough in Cancer Therapy. |
|
|
Apr 19, 2012 |
621 |
| Elekta Announces First Patients Treated with Major Breakthrough in Cancer Therapy. |
|
|
Apr 19, 2012 |
656 |
| Nuvilex Announces Invitation to Showcase Innovative Therapy for Cancer Treatment at Oncology Meeting in Kyoto, Japan. |
|
|
Apr 18, 2012 |
452 |
| Cancer Therapy Gets a Boost from New Isotope. |
|
|
Apr 11, 2012 |
998 |
| How cancer drug causes diabetic-like symptoms. |
|
|
Apr 4, 2012 |
305 |
| Pregnancies can survive some cancers, therapies. |
Sullivan, Michele G. |
|
Apr 1, 2012 |
2967 |
| Gene predicts response to esophagogastric cancer therapy. |
London, Susan |
|
Apr 1, 2012 |
696 |
| Study Establishes Safety and Clinical Benefit of SIR-Spheres[R] microspheres in Treating Metastatic Liver Tumors in Patients who Failed Systemic Chemotherapy. |
|
Clinical report |
Mar 27, 2012 |
615 |
| Cancer drug helps flush hidden HIV virus. |
|
|
Mar 9, 2012 |
376 |
| Research and Markets: The Global Cancer Drug Market to Grow At A CAGR Of 12.6 Percent over the Period 2010-2014. |
|
|
Mar 6, 2012 |
378 |
| Abbott and Merck Collaborate to Develop Companion Diagnostic Test for Investigational Cancer Therapy. |
|
|
Mar 6, 2012 |
555 |
| Nuvilex Reveals Goldman Small Cap Research Cites Groundbreaking Cancer Therapy in Updating Buy Recommendation. |
|
|
Feb 29, 2012 |
822 |
| New Drug Target Found for Lung Cancer. |
|
|
Feb 17, 2012 |
527 |
| Blocking DNA repair enzyme could eventually lead to cancer therapy. |
|
|
Feb 11, 2012 |
537 |
| Alithiasic cholecystitis treated by percutaneous cholecystostomy in a patient with severe septic shock and neutropenia. |
Simion, N. |
Case study |
Feb 1, 2012 |
919 |
| Bleomycin toxicity post injection into craniopharyngioma. |
Norval, Ivan L.; Tynan, Jennifer R.; Frangou, Evan M. |
Clinical report |
Feb 1, 2012 |
1000 |
| Ventana Medical Systems, Inc. to Collaborate with Bayer on Companion Diagnostic Test for New Biological Cancer Therapy. |
|
|
Jan 17, 2012 |
740 |
| Product Profiles: Targeted Cancer Therapies - Trend towards personalized medicine will lead to market fragmentation. |
|
|
Jan 16, 2012 |
682 |
| Viamet Pharmaceuticals Initiates Phase 1/2 Clinical Trial of Novel Prostate Cancer Therapy, VT-464. |
|
|
Jan 4, 2012 |
555 |
| Nanotechnology breakthrough for cancer patients. |
|
|
Jan 4, 2012 |
295 |
| CEL- SCI Corporation Updates Phase III Clinical Activities for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection). |
|
|
Dec 7, 2011 |
843 |
| Global Cancer Therapies Industry. |
|
Industry overview |
Dec 7, 2011 |
373 |
| Evolving research methods in cytology it's the era of laser scanning imaging-based technology. |
Gaisford, Wendy |
Report |
Dec 1, 2011 |
1795 |
| BBVA Foundation Unites the Efforts of Massachusetts General Hospital and Barcelona's Vall d'Hebron Hospital in Biomarker Research for Personalized Cancer Therapies. |
|
|
Nov 16, 2011 |
411 |
| CEL- SCI Corporation Updates Phase III Clinical Activities for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection). |
|
|
Nov 2, 2011 |
1237 |
| AgonOx Partners with MedImmune for Development of OX40 Agonists in Cancer Therapy. |
|
Clinical report |
Oct 31, 2011 |
696 |
| The Breast Cancer Drug Market Will Increase Marginally over the Next Decade, Despite Generic and Biosimilar Erosion of Key Agents. |
|
|
Oct 25, 2011 |
789 |
| Companiesandmarkets.com: Companion Diagnostics in Personalized Medicine and Cancer Therapy. |
|
|
Oct 20, 2011 |
252 |
| Nuvilex Announces an Additional Novel Approach to Cancer Therapy Utilizing Cell Encapsulation Technology. |
|
|
Oct 19, 2011 |
557 |
| Denosumab curbs bone loss from cancer therapy. |
|
|
Oct 15, 2011 |
311 |
| A randomized placebo controlled study on Viscum album (Iscador P) treatment of Equine Sarcoids in horses. |
Christen-Clottu, O.; Gerber, V.; Burger, D.; Klocke, P. |
Report |
Oct 15, 2011 |
412 |
| Cleave Biosciences Raises $42 Million in Series A Financing for Novel Cancer Therapies. |
|
|
Oct 11, 2011 |
916 |
| Steve Jobs' Death Highlights Critical Need for New Therapies for Pancreatic Cancer. |
|
|
Oct 10, 2011 |
571 |
| Protein discovery could pave way for new breast cancer therapy. |
|
|
Oct 6, 2011 |
179 |
| Aethlon Medical Announces Hemopurifier and HER2osome(TM) Cancer Therapy Presentation at Exosomes and Microvesicles 2011. |
|
|
Oct 5, 2011 |
1599 |
| Toxicity Concerns with Promising Accelerated Breast Cancer Therapy Unfounded, NSABP/West Penn Allegheny Researchers Find. |
|
|
Oct 3, 2011 |
418 |
| War on cancer: two new drugs emerge for melanoma. |
Moss, Ralph |
|
Oct 1, 2011 |
2311 |
| Epidermal growth factor receptor pathway mutations and colorectal cancer therapy. |
Grossmann, Allie H.; Samowitz, Wade S. |
|
Oct 1, 2011 |
3614 |
| Putting a cost on a life; Experts have said the cost of life-extending cancer drugs can't be justified, to the horror of many of those who are living - or have lived - with the disease. HANNAH DAVIES reports. |
|
|
Sep 30, 2011 |
360 |
| EGEN, Inc. Collaborates With Nanotechnology Characterization Laboratory on Brain Cancer Therapy. |
|
|
Sep 26, 2011 |
698 |
| Anticancer potential of ginger. |
Finney-Brown, Tessa |
Report |
Sep 22, 2011 |
465 |
| Oxygen plus MRI helps determine cancer therapy success. |
|
|
Sep 22, 2011 |
377 |
| Reversal effect of 2',4'-Dihydroxy-6'-methoxy-3',5'-dimethylchalcone on multi-drug resistance in resistant human hepatocellular carcinoma cell line BEL-7402/5-FU. |
Huang, Hai-ya; Niu, Jiang-long; Zhao, Li-ming; Lu, Yan-hua |
Report |
Sep 15, 2011 |
4223 |
| CEL-SCI's Taiwanese Partner Orient Europharma Presents Development Strategies in Taiwan for Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection) at World Orphan Drug Conference Today in Seoul, Korea. |
|
Conference news |
Sep 15, 2011 |
975 |
| SIUH Offers New 5-Day Breast Cancer Therapy. |
|
|
Sep 1, 2011 |
337 |
| Study Explores Utilization Trends for Prostate Cancer Treatments. |
|
|
Aug 31, 2011 |
503 |
| Tropical plant extracts offer new hope for effective ovarian cancer therapy. |
|
|
Aug 26, 2011 |
242 |
| Study of small molecules paves way for brain cancer therapy. |
|
|
Aug 23, 2011 |
395 |
| CEL-SCI Announces Exclusive Sales, Marketing and Distribution Agreement for Its Investigational Cancer Therapy Multikine (Leukocyte Interleukin, Injection) for Argentina and Venezuela. |
|
|
Aug 23, 2011 |
1016 |
| Oncobiologics, Inc. and Fox Chase Cancer Center Announce Co-Development of a Novel Cancer Therapy Platform. |
|
|
Aug 22, 2011 |
656 |
| Angiogenesis Research Pioneer Robert S. Kerbel, Ph.D. to be Keynote Speaker at the Angiogenesis Foundation's 2011 M. Judah Folkman Conference: New Frontiers in Therapeutic Development. |
|
Conference news |
Aug 18, 2011 |
398 |
| Pfizer Announces European Medicines Agency Acceptance of Regulatory Submissions For Two Investigational Cancer Therapies. |
|
|
Aug 17, 2011 |
1711 |
| SIUH Offers New 5-Day Breast Cancer Therapy. |
|
|
Aug 3, 2011 |
417 |
| Comorbidities and cognitive functioning: implications for nursing research and practice. |
Vance, David; Larsen, Kirsten I.; Eagerton, Gregory; Wright, Mary A. |
|
Aug 1, 2011 |
6741 |
| Breast cancer: prevention, detection targeting molecular markers. |
Jurasunas, Serge |
Report |
Aug 1, 2011 |
4585 |
| Curcumin compound boosts head and neck cancer therapy. |
Dye, D. |
Brief article |
Aug 1, 2011 |
199 |
| Space secrets could lead to superior cancer therapies. |
|
|
Jul 29, 2011 |
213 |
| Biocept, Inc. Announces Availability of Its New Breast Cancer Test, OncoCEE-BR(TM) Utilizing Circulating Tumor Cells (CTCs). |
|
|
Jul 28, 2011 |
1134 |
| Mentor Capital Seeks Partners as Neutron Cancer Therapy Investee Accelerates Path to Treatment and Increased Valuation. |
|
|
Jul 26, 2011 |
365 |
| Provenge vs. Robotic Prostatectomy. |
|
|
Jul 18, 2011 |
965 |
| Research and Markets: Companion Diagnostics in Personalized Medicine and Cancer Therapy - A Near-Term Market Opportunity for Cancer Companion Diagnostic Tests. |
|
|
Jul 15, 2011 |
368 |
| Novian Health Receives FDA Approval to Study Breast Cancer Therapy. |
|
|
Jul 14, 2011 |
650 |
| Research and Markets: 'Advancing Molecular Diagnostics to Personalize Cancer Therapy' report analyzes current and potential world markets. |
|
|
Jul 11, 2011 |
478 |
| Modernizing cancer drug discovery. |
Torrance, Chris |
|
Jul 1, 2011 |
1748 |
| The evolution of a novel form of cancer therapeutics. |
|
|
Jul 1, 2011 |
1456 |
| Combination Therapies Are Becoming the Cancer Treatment of Choice: companiesandmarkets.com. |
|
Disease/Disorder overview |
Jun 28, 2011 |
440 |
| Nuvilex Anticipates Enhancement of Multi-Drug Cancer Therapies by Inclusion of Encapsulated Cells. |
|
|
Jun 16, 2011 |
678 |
| ZIOPHARM Oncology Announces Acceptance of Investigational New Drug Application for ZIN ATI-001 (Ad-RTS-IL-12), a Novel DNA-Based Oncology Therapeutic Candidate. |
|
Clinical report |
Jun 10, 2011 |
1043 |
| New therapy that pushes colon cancer cells to death discovered. |
|
|
Jun 9, 2011 |
238 |
| Fighting Cancer with Cancer: Mayo Clinic Finds Promising Use for Thyroid Cancer Gene. |
|
|
Jun 8, 2011 |
730 |
| Fox Chase Cancer Center Study Evaluating the Safety of Concurrent Chemotherapy and Selective Internal Radiation Therapy using SIR-Spheres[R] Microspheres Released at 2011 American Society of Clinical Oncology Annual Meeting. |
|
|
Jun 3, 2011 |
1170 |
| Combination of two targeted drugs appears safe. |
McBride, Deborah |
Brief article |
Jun 1, 2011 |
214 |
| Research and Markets: DNA Repair in Cancer Therapy: Molecular Targets and Clinical Applications. |
|
|
May 25, 2011 |
509 |
| Abbott Completes Submission of New Molecular Test Intended for Non-small-cell Lung Cancer Therapy Selection. |
|
|
May 23, 2011 |
573 |
| Majority of Physicians Using Herceptin as Key Therapy for Gastric Cancer, But Satisfaction With Treatment Options Remains Low, According to Oncology Tracking Study by GfK HealthCare. |
|
Report |
May 17, 2011 |
594 |
| ZIOPHARM Oncology Files Investigational New Drug Application for Ad-RTS-IL-12, a Novel DNA-Based Oncology Therapeutic Candidate. |
|
Clinical report |
May 13, 2011 |
1226 |
| Research and Markets: Case Study: Personalized Cancer Therapy - The era of biomarker identification and companion diagnostic co-development. |
|
|
May 3, 2011 |
449 |
| Updates on preclinical studies on natural anti-cancer agents: results call for increased federal funding of human trials. |
Cohen, Marcus A. |
|
May 1, 2011 |
2124 |
| Experimental evaluation of snake venom as an anticancer agent. |
Gomes, Aparna |
Report |
May 1, 2011 |
511 |
| New Class of Instruments for Flexible Surgery from Apollo Endosurgery Used in Cancer Therapy. |
|
|
Apr 19, 2011 |
562 |
| VBL Therapeutics Presents Two Studies on Novel Anti-Angiogenic Vector at 102nd Annual AACR Meeting. |
|
|
Mar 31, 2011 |
461 |
| Novel immune therapy for pancreatic cancer discovered. |
|
|
Mar 25, 2011 |
468 |
| Life work culminates in testing of cancer therapy in humans. |
|
|
Mar 24, 2011 |
418 |
| Cellerant Therapeutics Initiates a Phase I/II Clinical Trial of CLT-008 for Chemotherapy Induced Neutropenia in Acute Leukemia Patients. |
|
|
Mar 22, 2011 |
886 |
| No spike seen in infection rates after rituximab therapy. |
Mahoney, Diana |
|
Mar 15, 2011 |
518 |
| Teysuno(TM) (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer. |
|
|
Mar 14, 2011 |
953 |
| Teysuno(TM) (S-1) Receives European Marketing Authorization as First-Line Therapy for Advanced Gastric Cancer. |
|
|
Mar 14, 2011 |
966 |
| PNP Therapeutics Meets Important Financial and Regulatory Objectives in Development of New Cancer Therapies. |
|
|
Mar 10, 2011 |
646 |
| Health Robotics Announces i.v.STATION(R) ONCO, a Next Generation Robot for Intravenous Cancer Therapy. |
|
|
Mar 7, 2011 |
895 |
| New personalized therapy to 'fool cancer cells into killing themselves'. |
|
|
Mar 3, 2011 |
474 |
| New personalized therapy to 'fool cancer cells into killing themselves'. |
|
|
Mar 2, 2011 |
474 |
| Lixte Biotechnology Holdings, Inc. Awarded Grant Under Qualifying Therapeutic Discovery Project from the U. S. Government. |
|
|
Mar 2, 2011 |
732 |
| BSD Medical Announces the Inclusion of Hyperthermia and Chemotherapy as a Recommended Cancer Treatment for High Risk Sarcoma in the NCCN Practice Guidelines. |
|
|
Feb 24, 2011 |
856 |
| Whole Genome Sequencing Used to Help Inform Cancer Therapy. |
|
|
Feb 16, 2011 |
1133 |
| DUO IN CANCER CARE DEMAND. |
|
|
Feb 5, 2011 |
765 |
| LILLY (ELI) & COMPANY - Necitumumab Trial DMC. |
|
|
Feb 3, 2011 |
2864 |
| Campaigner calls for 'more robust' cancer screening; Herceptin heroine faces AMs. |
|
|
Feb 2, 2011 |
477 |
| Reportlinker Adds Oncology Market in China to 2017 - Better Access to Cancer Therapies for the Rising Cancer Population through Healthcare Reforms Drives the Market. |
|
|
Jan 20, 2011 |
674 |
| Kingdom, Japan to exchange experience in cancer therapy. |
|
|
Jan 19, 2011 |
270 |
| Artemisinin inhibits in vitro and in vivo invasion and metastasis of human hepatocellular carcinoma cells. |
Weifeng, Tan; Feng, Shen; Xiangji, Luo; Changqing, Su; Zhiquan, Qiu; Huazhong, Zeng; Peining, Yan; Y |
Report |
Jan 15, 2011 |
3948 |
| New potential target for breast cancer therapy identified. |
|
Disease/Disorder overview |
Dec 23, 2010 |
243 |
| Aethlon Medical Demonstrates Ability to Capture Colorectal and Lymphoma Cancer Exosomes. |
|
|
Dec 20, 2010 |
1724 |
| Teysuno(TM) (S-1) Receives CHMP Positive Opinion for Approval as First-Line Therapy for Advanced Gastric Cancer. |
|
|
Dec 17, 2010 |
1174 |
| Teysuno(TM) (S-1) Receives CHMP Positive Opinion for Approval as First-Line Therapy for Advanced Gastric Cancer. |
|
|
Dec 17, 2010 |
1193 |
| Response Genetics Announces New Data Supporting the Use of Gene Expression to Help Personalize Cancer Therapy Selection. |
|
Clinical report |
Dec 13, 2010 |
1323 |
| Pomegranate juice could be key to new cancer therapies. |
|
|
Dec 13, 2010 |
291 |
| Angelica Therapeutics Receives a $244,479 Qualified Therapeutic Discovery Project Grant for Its Anti-Cancer Drug. |
|
|
Dec 9, 2010 |
404 |
| EDAP TO COLLABORATE ON USE OF HIFU IN CANCER DRUG DELIVERY. |
|
Company overview |
Dec 1, 2010 |
583 |
| Anti-angiogenic effect of siphonaxanthin from green alga, Codium fragile. |
Ganesan, Ponesakki; Matsubara, Kiminori; Ohkubo, Takeshi; Tanaka, Yukihisa; Noda, Kenji; Sugawara, T |
|
Dec 1, 2010 |
4459 |
| Radiation therapy of a malignant melanoma in a thick-billed parrot (Rhynchopsitta pachyrhyncha). |
Guthrie, Amanda L.; Gonzalez-Angulo, Carlos; Wigle, William L.; deMaar, Thomas W. |
Clinical report |
Dec 1, 2010 |
2588 |
| Studies Reconfirm Significant Benefits Regarding the Use of SIR-Spheres[R] Microspheres for the Treatment of Inoperable Liver Tumors. |
|
Clinical report |
Nov 30, 2010 |
1486 |
| Epeius Biotechnologies Awarded Federal Grant Advancing Tumor-Targeted Cancer Therapy. |
|
|
Nov 8, 2010 |
582 |
| Bio-Path Holdings Awarded Grant from the U.S. Government's Qualifying Therapeutic Discovery Project Program. |
|
|
Nov 3, 2010 |
669 |
| Reportlinker Adds Commercial Insight Top 20 Cancer Therapy Brands Forecast. |
|
|
Nov 3, 2010 |
467 |
| Genta Awarded Two Federal Grants Totaling $488,958 for Qualifying Therapeutic Discovery Projects. |
|
|
Nov 2, 2010 |
965 |
| Prostate Oncology Specialists Among First in the Nation to Treat Advanced Prostate Cancer Patients With PROVENGE. |
|
|
Oct 27, 2010 |
991 |
| Research and Markets: Top 20 Cancer Therapy Brands: Top 20 Brands Account for 75% of Market. |
|
|
Oct 8, 2010 |
482 |
| Low IgG poses infection risk with Rituxan. |
|
|
Oct 5, 2010 |
626 |
| Dendreon Announces Presentation of PROVENGE Data at the 25th International Society for Biological Therapy of Cancer Annual Meeting. |
|
|
Oct 1, 2010 |
1082 |
| HUYA Bioscience and Quintiles Announce Partnership for Phase I Development of New Cancer Therapy. |
|
|
Sep 28, 2010 |
824 |
| Vitamin supplements 'up skin cancer risk'. |
|
|
Sep 28, 2010 |
325 |
| Zalicus Presents Data on Oncology Programs at Targeted Cancer Therapies World Europe 2010. |
|
|
Sep 23, 2010 |
510 |
| Stress before cancer therapy may sabotage treatment. |
|
|
Sep 22, 2010 |
288 |
| Adopting 'synthetic lethality' could boost molecularly targeted cancer therapy. |
|
|
Sep 22, 2010 |
370 |
| Scientists Create New Process to 'Program' Cancer Cell Death. |
|
|
Sep 16, 2010 |
644 |
| Prostate Cancer Patients Go to School. |
|
|
Sep 10, 2010 |
368 |
| Gene set shows which patients benefit from chemo after surgery. |
|
Clinical report |
Sep 8, 2010 |
344 |
| New discovery could stop stem-cell loss during cancer therapy. |
|
|
Sep 6, 2010 |
211 |
| Gamma secretase and Notch as therapeutic targets in cancer. |
Filipovic, Aleksandra; Giamas, Georgios; Coombes, R. Charles; Stebbing, Justin |
|
Sep 1, 2010 |
3141 |
| Getting the details right: Gene signatures for cancer therapy. |
Master, Stephen R. |
|
Sep 1, 2010 |
1871 |
| China PharmaHub Corp. Introduces a 'Magic Bullet' Liver Cancer Therapy to China, Hong Kong, Taiwan, Macau, Singapore, Malaysia, and Bangladesh. |
|
|
Aug 26, 2010 |
1212 |
| FDA-approved cancer drugs that may fight HIV identified. |
|
|
Aug 21, 2010 |
214 |
| US Oncology Helps Deliver Latest Cancer Therapies Through Local Community Access to Cutting Edge Research. |
|
|
Aug 19, 2010 |
1351 |
| HemaQuest Pharmaceuticals Initiates Phase 2 Clinical Trial in EBV-Related Malignancies. |
|
|
Aug 11, 2010 |
888 |
| Recurrent vascular leiomyoma of the larynx: Clinical and histopathologic characteristics and treatment. |
Hirshoren, Nir; Weinberger, Jeffrey M.; Neuman, Tzahi; Ilan, Ophir; Ben-Yaakov, Avraham |
Report |
Aug 1, 2010 |
1516 |
| How to target mutant p53 in a case of multiple cancer recurrence. |
Jurasunas, Serge; Taylor, Olga Galkina |
Report |
Aug 1, 2010 |
2510 |
| Research and Markets: This Essential Global Breast Cancer Drugs Market Report with Forecasts Through 2009-2013 is Now Available. |
|
Industry overview |
Jul 26, 2010 |
405 |
| Research and Markets: Global Cancer Drugs market 2009-2013 Hightlights the Trends, Drivers, Growth Inhibitors and A Few Major Vendors in the Market. |
|
Industry overview |
Jul 23, 2010 |
489 |
| Seattle Genetics and Agensys, an Affiliate of Astellas, Announce Initiation of Phase I Clinical Trial of ASG-5ME for Pancreatic Cancer. |
|
|
Jul 20, 2010 |
1048 |
| Epizyme Scientists Detail Epigenetic Approaches to Cancer Therapy in Drug Discovery Today: Therapeutic Strategies and Current Opinion in Chemical Biology. |
|
|
Jul 16, 2010 |
486 |
| Medication reuse: a safer, better system is needed. |
Tariman, Joseph D. |
|
Jul 1, 2010 |
532 |
| Which dose of busulfan is best? |
Johnson-Davis, Kamisha L.; McMillin, Gwendolyn A.; Juenke, JoEtta M.; Ford, Clyde D.; Petersen, Finn |
|
Jul 1, 2010 |
3475 |
| Riverside & University of Virginia Radiosurgery Center Surpasses 1,000(th) Patient Mark, High Demand for Ultra-Targeted Brain and Body Cancer Therapy. |
|
|
Jun 23, 2010 |
1072 |
| Hospital opens cancer therapy centre. |
|
|
Jun 20, 2010 |
165 |
| Galera Therapeutics Secures Funding for New Cancer Treatment. |
|
|
Jun 15, 2010 |
855 |
| New Cancer Treatments and Combination Therapies Presented by Leading Experts from the John Theurer Cancer Center at the American Society of Clinical Oncology Annual Meeting. |
|
|
Jun 3, 2010 |
1376 |
| Blocking DNA repair protein likely to make cancer therapy safer. |
|
|
Jun 2, 2010 |
495 |
| Health Robotics South East Asia Wins two key Cancer Therapy Outsourcing Projects in Malaysia and Thailand. |
|
|
May 31, 2010 |
621 |
| Health Robotics South East Asia Wins two key Cancer Therapy Outsourcing Projects in Malaysia and Thailand. |
|
|
May 31, 2010 |
626 |
| CEL-SCI Announces Presentation by Its Chief Scientific Officer at "Targeted Cancer Therapies" Conference in London Today. |
|
Conference news |
May 27, 2010 |
435 |
| Key to individualized cancer therapy via gene silencing found. |
|
|
May 27, 2010 |
359 |
| Promising new strategy for cancer therapy. |
|
|
May 27, 2010 |
372 |
| Research and Markets: Lung Cancer and Non-Small Cell Lung Cancer Therapy Area Pipeline Report. |
|
Report |
May 21, 2010 |
332 |
| Research and Markets: Skin Cancer and Melanoma Therapy Area Pipeline Report. |
|
Report |
May 19, 2010 |
320 |
| Hotline for cancer therapy. |
|
|
May 18, 2010 |
112 |
| FDA CONSUMER HEALTH INFORMATION - FDA Approves New Prostate Cancer Therapy. |
|
|
May 5, 2010 |
286 |
| Antitumor activity of terpenoids against classical and atypical multidrug resistant cancer cells. |
Lage, H.; Duarte, N.; Coburger, C.; Hilgeroth, A.; Ferreira, M.J.U. |
|
May 1, 2010 |
6210 |
| ONCOLYTICS BIOTECH BEGINS PHASE 2 SCC LUNG CANCER TRIAL. |
|
|
May 1, 2010 |
750 |
| FDA Approves Tarceva as a Maintenance Therapy for Advanced Non-Small Cell Lung Cancer. |
|
|
Apr 17, 2010 |
1064 |
| Sir John takes a holiday before cancer therapy; TYCOON JETS OFF TO RELAX IN PREPARATION FOR TREATMENT. |
|
|
Apr 10, 2010 |
579 |
| Reportlinker Adds Top 20 Cancer Therapy Brands in Australia Forecast. |
|
|
Apr 1, 2010 |
442 |
| InNexus Bio DXL[TM] Antibody Technology Causes Cancer Cell Death By Mechanisms Not Seen with Current Market-Leading Medications. |
|
|
Mar 23, 2010 |
561 |
| Health Discovery Corporation and Smart Personalized Medicine Form Agreement for Developing Laboratory Tests for Breast Cancer Therapy Selection with Quest Diagnostics. |
|
|
Mar 17, 2010 |
480 |
| Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. |
Iranshahi, M.; Sahebkar, A.; Hosseini, S.T.; Takasaki, M.; Konoshima, T.; Tokuda, H. |
Clinical report |
Mar 1, 2010 |
4286 |
| Synta Pharmaceuticals to Participate in Panel Titled New Targets in Cancer Therapy at the RBC Capital Markets Healthcare Conference. |
|
Conference news |
Feb 23, 2010 |
190 |
| The Hamner Institutes and Oslo Cancer Cluster Announce Partnership; - Memorandum Of Understanding Strengthens European Arm of Global Biosciences Gateway. |
|
|
Feb 18, 2010 |
773 |
| Medical stock spotlight: Rexahn Pharmaceuticals Inc. |
|
|
Feb 15, 2010 |
381 |
| Prostate Cancer Therapy Can Increase Heart Risk Factors. |
|
|
Feb 2, 2010 |
926 |
| Townsend's New York observer: Third Column on knockout, a book on Cancer, by Suzanne Somers. |
Cohen, Marcus A. |
Column |
Feb 1, 2010 |
2295 |
| New cancer drug blocks master protein. |
McBride, Deborah |
Brief article |
Feb 1, 2010 |
231 |
| Research and Markets: Targeting Protein Kinases for Cancer Therapy: An Expert Guide to Targeting Protein Kinases in Cancer Therapy. |
|
|
Jan 29, 2010 |
313 |
| New therapeutic target for leukaemia identified. |
|
|
Jan 28, 2010 |
318 |
| ACT BIOTECH Announces FDA Acceptance of IND for ACTB1003, a First-in-Class Anti-Cancer Therapeutic. |
|
|
Jan 22, 2010 |
426 |
| New breast cancer therapy decreases mastectomies. |
|
|
Jan 20, 2010 |
269 |
| Why certain anticancer cancer drugs cause heart failure. |
|
|
Jan 12, 2010 |
200 |
| Research and Markets: Dealmaking and Industry Outlook: Targeted Cancer Therapies Report. |
|
Report |
Jan 4, 2010 |
815 |
| Oncology nurses can help patients save costs by managing their medications. |
Wujcik, Debra M. |
Editorial |
Jan 1, 2010 |
439 |
| Breast cancer drug may reduce risk of death from lung cancer. |
|
|
Dec 12, 2009 |
254 |
| Semafore Pharmaceuticals Reports Encouraging Phase I Data at ASH for Novel PI3K/mTOR Pathway Inhibitor. |
|
|
Dec 8, 2009 |
863 |
| Cranial MRI diagnosis. |
Misser, S.K. |
Brief article |
Dec 1, 2009 |
108 |
| Myomin: natural aromatase inhibitor for estrogen-related conditions. |
Chi, Tsu-Tsair |
Report |
Dec 1, 2009 |
4809 |
| Primary sinonasal malignant melanoma: a clinicopathologic and prognostic study. |
Kumar, Sudesh; Gupta, Ashok K.; Yadav, Budhi S.; Ghoshal, Sushmita |
Clinical report |
Dec 1, 2009 |
2461 |
| Chlorophyllin-chemo cocktail proposed. |
Dye, Dayna |
Brief article |
Dec 1, 2009 |
159 |
| ThromboGenics and BioInvent Complete Phase I Patient Trial of Anti-PlGF Cancer Therapeutic TB-403 in Patients With Advanced Solid Tumours. |
|
|
Nov 16, 2009 |
1040 |
| Nanoparticle Cancer Therapies Synthesized to Surf Bloodstream. |
|
|
Nov 15, 2009 |
339 |
| Cancer therapy center. |
|
|
Nov 1, 2009 |
106 |
| Correlation of selected molecular markers in chemosensitivity prediction. |
King, David; Keane, Thomas; Hu, Wei |
Report |
Nov 1, 2009 |
6028 |
| New drug against cancer stem cells may prevent disease recurrence and spread. |
McBride, Deborah |
|
Nov 1, 2009 |
481 |
| New Animal Study Featured in the Journal of Cellular Biochemistry Supports Rexahn's Archexin[TM] as Potent Inhibitor of Human Cancer Cell Growth. |
|
|
Oct 22, 2009 |
573 |
| Pre-targeting approach may lead to personalised cancer therapies. |
|
|
Oct 12, 2009 |
358 |
| SAVI Breast Cancer Therapy Featured on "The Doctors" TV Show. |
|
|
Oct 6, 2009 |
430 |
| Pre-targeting approach may lead to personalised cancer therapies. |
|
|
Oct 5, 2009 |
358 |
| Curcumin inhibits cell proliferation of MDA-MB-231 and BT-483 breast cancer cells mediated by down-regulation of NF[kappa]B, cyclinD and MMP-1 transcription. |
Liu, Q.; Loo, Wings T.Y.; Sze, S.C.W.; Tong, Y. |
Report |
Oct 1, 2009 |
3281 |
| Cetuximab drug with chemo may cut death risk in lung cancer patients. |
|
|
Sep 22, 2009 |
310 |
| Research and Markets: Prostate Cancer Therapy Area Pipeline Report: Status of Prostate Cancer Drugs by Company and by Stage and Summary of the Latest News and Developments. |
|
Report |
Sep 11, 2009 |
352 |
| Research and Markets: Ovarian Cancer Therapy Area Pipeline Report. |
|
Report |
Sep 11, 2009 |
352 |
| New discovery may help in developing effective cancer therapies. |
|
|
Sep 3, 2009 |
328 |
| Complete Guide to Complementary & Alternative Cancer Therapies, second edition. |
|
Book review |
Sep 1, 2009 |
99 |
| Radiation resistance in breast cancer. |
Kunkler, Ian |
Report |
Sep 1, 2009 |
3262 |
| PET and PET-CT imaging of breast cancer. |
Brunetti, Jacqueline C. |
Report |
Sep 1, 2009 |
4883 |
| Cancer drug 'raises rare tumour risk' HEALTH. |
|
|
Aug 26, 2009 |
142 |
| New risks of cancer drug; WORLDTODAY. |
|
|
Aug 26, 2009 |
112 |
| Reportlinker Adds Molecular Targeted Cancer Therapies Market Forecast. |
|
|
Aug 25, 2009 |
179 |
| Research and Markets: Gastrointestinal (Stomach) Cancer Therapy Area Pipeline Report - Drug Status by Company and by Stage as Well as a Summary of the Latest News and Developments. |
|
Report |
Aug 25, 2009 |
350 |
| Clinical Data, Inc. Announces Collaboration with CombinatoRx for the Development of Novel B-Cell Cancer Therapy. |
|
|
Aug 13, 2009 |
812 |
| Research and Markets: A Comprehensive and Detailed Report on Colorectal Cancer or Colon Cancer Therapy Area Pipeline. |
|
Report |
Aug 12, 2009 |
363 |
| Research and Markets: Head and Neck Cancer Therapy Area Pipeline Report - Detailed Information on the Head and Neck Cancer Drug Pipeline. |
|
Report |
Aug 12, 2009 |
360 |
| Research and Markets: Breast Cancer Therapy Area Pipeline Report: Extensive Details on Drug Pipelines by Company and Stage and Latest Company News. |
|
Report |
Aug 12, 2009 |
352 |
| Hartson prepares for cancer therapy; FOOTBALL. |
|
|
Aug 4, 2009 |
119 |
| War on cancer: New York Times criticizes war on cancer. |
Moss, Ralph |
|
Aug 1, 2009 |
2300 |
| Vitamins vs. chemotherapy and radiation for cancer therapy. |
Houston, Reagan |
Clinical report |
Aug 1, 2009 |
1420 |
| The effect of alkalizing agents on malignant processes, from cytotoxic to genomic in cancer research. |
Bradford, Robert W. |
Clinical report |
Aug 1, 2009 |
3510 |
| Phyllanthus urinaria extract attenuates acetaminophen induced hepatotoxicity: involvement of cytochrome P450 CYP2E1. |
Hau, Desmond Kwok Po; Gambari, Roberto; Wong, Raymond Siu Ming; Yuen, Marcus Chun Wah; Cheng, Gregor |
Report |
Aug 1, 2009 |
5369 |
| Response Genetics to Present New Data at the 13th World Conference on Lung Cancer Supporting the Use of Gene Expression to Help Personalize Cancer Therapy Selection. |
|
Conference news |
Jul 31, 2009 |
1095 |
| BioAlliance Pharma Signs a Co-Promotion Agreement with Lundbeck for in-Hospital Prescription of the Antidepressant Seroplex[R]. |
|
|
Jul 21, 2009 |
399 |
| Research and Markets: Lymphoma Drug Development Strategies at Work: New Report Includes Defined and Up to Date Development Strategies for 176 Lymphoma Therapeutic Drugs. |
|
|
Jul 17, 2009 |
380 |
| New 'minicell therapy' to crash cancer resistance. |
|
|
Jun 29, 2009 |
364 |
| New light-sensitive compounds may revolutionize cancer therapy. |
|
|
Jun 17, 2009 |
431 |
| Research and Markets: Bladder Cancer Therapy Area Pipeline Report - A Detailed Information on the Bladder Cancer Drug Pipeline. |
|
Report |
Jun 12, 2009 |
313 |
| Reportlinker Adds Diagnostics Bundle. |
|
|
Jun 9, 2009 |
2065 |
| Oxygen, MRI combo may help determine cancer therapy success. |
|
|
Jun 4, 2009 |
277 |
| Advanced Cancer Therapeutics Secures Exclusive License to Anti-Cancer Therapeutic from the University of Louisville's Brown Cancer Center. |
|
|
Jun 3, 2009 |
470 |
| Silibinin prevents TPA-induced MMP-9 expression and VEGF secretion by inactivation of the Raf/MEK/ERK pathway in MCF-7 human breast cancer cells. |
Kim, Sangmin; Choi, Jae Hyuck; Lim, Hye In; Lee, Se-Kyung; Kim, Wan Wook; Kim, Jee Soo; Kim, Jung-Ha |
Report |
Jun 1, 2009 |
3739 |
| Research and Markets: Cancer Drug Discoveries: What the Future Holds for the Non-Small Cell Lung Cancer Market and Therapeutic Approaches. |
|
|
May 26, 2009 |
774 |
| Popular cancer drug rituximab may lead to oft-fatal viral brain infection. |
|
|
May 19, 2009 |
417 |
| Targeted therapy agent for lung cancer to be introduced in UAE soon. |
|
|
May 17, 2009 |
1178 |
| Glivec(R) is the First Adjuvant Treatment Approved in the UK to Delay Return of Gastrointestinal Cancer After Surgery. |
|
|
May 8, 2009 |
1426 |
| Prostate cancer therapy 'ups risk of bone, heart-related problems'. |
|
|
Apr 27, 2009 |
229 |
| Cancer Therapy & Research Center at The University of Texas Health Science Center and OncoVista Innovative Therapies, Inc. Announce the Initiation of Collaboration on the Clinical Development of OVI-117. |
|
|
Apr 7, 2009 |
624 |
| Femara downstaged tumors to operable size. |
McNamara, Damian |
|
Apr 1, 2009 |
591 |
| The Western Pennsylvania Hospital Joins Prominent Group of Cancer Centers Exploring New Therapy for Leukemia and Lymphoma Patients. |
|
|
Mar 19, 2009 |
781 |
| First FDA-approved chemo agent turns 60. |
Bates, Betsy |
|
Mar 1, 2009 |
1197 |
| The role of biologicals in the management of metastatic colorectal cancer. |
Van Cutsem, Eric |
Report |
Mar 1, 2009 |
1321 |
| Green tea blocks cancer drug. |
|
Brief article |
Mar 1, 2009 |
115 |
| Mogoltacin enhances vicristine cytotoxicity in human transitional cell carcinoma (TCC) cell line. |
Rassouli, Behnam F.; Matin, M.M.; Iranshahi, M.; Bahrami, A.R.; Neshati, V.; Mollazadeh, S.; Neshati |
Report |
Mar 1, 2009 |
4743 |
| Nebrodeolysin, a novel hemolytic protein from mushroom Pleurotus nebrodensis with apoptosis-inducing and anti-HIV-1 effects. |
Lv, Hui; Kong, Yang; Yao, Qing; Zhang, Bo; Leng, Fang-wei; Bian, He-jiao; Balzarini, Jan; Damme, Els |
Report |
Mar 1, 2009 |
4455 |
| SAVI Device Expands Access to Shorter Breast Cancer Therapy, Peer-Reviewed Article Finds. |
|
|
Feb 17, 2009 |
573 |
